. . . "Take without regard to meals. Avoid alcohol."@en . . . "Avoid high doses of caffeine."@en . . . . . . . "In 2005, the Food and Drug Administration (FDA) withdrew approval for pemoline. In March 2005, Abbott Laboratories (Cylert marketer) had discontinued the production of Cylert arguing economic reasons."@en . "Pemoline is excreted primarily by the kidneys with approximately 50% excreted unchanged and only minor fractions present as metabolites."@en . . "2152-34-3"@en . . . "Side effects include insomnia, anorexia, stomach ache, skin rashes, increased irritability, mild depression, nausea, dizziness, headache, drowsiness, and hallucinations"@en . . . . "Pemoline"@en . . . "Humans and other mammals"@en . . . . . "withdrawn"@en . . . . . "For treatment of Attention Deficit Hyperactivity Disorder (ADHD)"@en . . . . . . . . . . . . "The serum half-life of pemoline is approximately 12 hours."@en . . . "Approximately 50% (bound to plasma proteins)."@en . . . . "Pemoline is rapidly absorbed from the gastrointestinal tract"@en . . "illicit"@en . . . . . . . . . .